Industries Biotechnology Health Care Therapeutics Headquarters Location Cambridge, Massachusetts, United States Headquarters Regions Greater Boston Area, East Coast, New England Founded Date 2014 Founders Dario Campana Operating Status Active Last Funding Type Post-IPO Equity Legal Name Unum Therapeutics Inc. Stock Symbol NASDAQ:UMRX Company Type For Profit Contact Email firstname.lastname@example.org Phone Number (617) 843-5032
Unum Therapeutics uses proprietary T-cell engineering technology in combination with tumor-targeting antibodies to activate the body’s own immune system to fight cancer. Unum’s lead program, based on its Antibody-Coupled T-cell Receptor (ACTR) technology, is expected to enter Phase I clinical testing in the coming months to assess safety and efficacy. Unum is seeking partners interested in using the ACTR technology to arm proprietary tumor-specific antibodies with a T-cell to improve their therapeutic potential. The company is headquartered in Cambridge, MA.